Philips to Acquire Intact Vascular for $360M
Shots:
- Philips will acquire Intact Vascular for $275M up front and deferred payments of $85M upon completion of the transaction. The transaction is expected to be completed in Q3’20
- The collaboration will expand Philips’ image-guided therapy portfolio with the addition of Intact Vascular’s Tack endovascular system- that reinforces standard and drug-coated balloon PAD treatment results
- Intact Vascular’s Tack implant is a minimal-metal- dissection repair device that provides precision treatment of peripheral arterial dissections following balloon angioplasty in ATK and BTK therapeutic interventions
Ref: Philips | Image: Philips
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com